# Prelude Therapeutics Inc: Form SC 13D/A, filed Jan 14, 2021

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: SC 13D/A
- Filed: 2021-01-14
- Accepted by EDGAR: Jan 13, 2021, 17:34 ET
- Period: not reported
- Accession: 0000947871-21-000059
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000094787121000059/ss189862_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000094787121000059/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000094787121000059/ss189862_sc13da.htm

Filed Jan 14, 2021.
Source: SEC EDGAR, the filing index for accession 0000947871-21-000059. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
